These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8877764)

  • 1. Lymphocyte responses to human cytomegalovirus in different groups of patients in Britain and in adults from west Africa and the Middle East.
    Omisakin KA; Davidson F; Bevan DH; al Nakib W; Abdel Wahab KS; Booth JC
    J Med Virol; 1996 Aug; 49(4):311-8. PubMed ID: 8877764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus-directed lymphocyte reactivity in healthy adults tested by a CMV-induced lymphocyte transformation test.
    Ten Napel CH; The TH; Bijker J; De Gast GC; Langenhuysen MM
    Clin Exp Immunol; 1977 Jul; 29(1):52-60. PubMed ID: 70294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte transformation test responses to cytomegalovirus in healthy adults from Britain and Iraq.
    Booth JC; Rashid SA; Aziz TA
    J Med Virol; 1987 Nov; 23(3):265-72. PubMed ID: 2828523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: interleukin-1 and interleukin-2 modify in vitro responses.
    Sheridan JF; Aurelian L; Donnenberg AD; Quinn TC
    J Clin Immunol; 1984 Jul; 4(4):304-11. PubMed ID: 6086703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective defects in cytomegalovirus- and mitogen-induced lymphocyte proliferation and interferon release in patients with acquired immunodeficiency syndrome.
    Epstein JS; Frederick WR; Rook AH; Jackson L; Manischewitz JF; Mayner RE; Masur H; Enterline JC; Djeu JY; Quinnan GV
    J Infect Dis; 1985 Oct; 152(4):727-33. PubMed ID: 2413136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immune response to human cytomegalovirus. I. Lymphocyte transformation studies in the rabbit.
    Lausch RN; Jones C; Christensen RC
    Intervirology; 1979; 11(2):74-81. PubMed ID: 85612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific lymphocyte blastogenic responses in children with cytomegalovirus and herpes simplex virus infections acquired early in infancy.
    Pass RF; Dworsky ME; Whitley RJ; August AM; Stagno S; Alford CA
    Infect Immun; 1981 Oct; 34(1):166-70. PubMed ID: 6271679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure.
    Nakamura R; Battiwalla M; Solomon S; Follmann D; Chakrabarti S; Cortez K; Hensel N; Childs R; Barrett AJ
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):49-57. PubMed ID: 14752779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cellular immune response to cell-associated and cell-free cytomegalovirus (CMV) antigens after primary CMV-infection in non-immunocompromised hosts: development and maintenance of CMV-latency and its influence on immunocompetence.
    Roenhorst HW; Kallenberg CG; The TH
    Clin Exp Immunol; 1988 Dec; 74(3):326-32. PubMed ID: 2853014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients.
    Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Adler SP
    J Clin Virol; 2006 Mar; 35(3):332-7. PubMed ID: 16387547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro stimulation of human lymphocytes by purified cytomegalovirus.
    Moller-Larsen A; Andersen HK; Heron I; Sarov I
    Intervirology; 1975-1976; 6(4-5):249-57. PubMed ID: 186434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of interleukin 2 and large envelope glycoprotein (gp 120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus.
    Krowka J; Stites D; Mills J; Hollander H; McHugh T; Busch M; Wilhelm L; Blackwood L
    Clin Exp Immunol; 1988 May; 72(2):179-85. PubMed ID: 2842093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immune responses to herpes simplex virus, varicella-zoster and cytomegalovirus in vitro.
    Williamson SA; Parish N; Chambers JD; Knight RA
    Immunology; 1986 Mar; 57(3):437-42. PubMed ID: 3007334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of cytomegalovirus, human parvovirus B19, and herpes simplex virus-1/2 in women with first-trimester spontaneous abortions.
    Zhou Y; Bian G; Zhou Q; Gao Z; Liao P; Liu Y; He M
    J Med Virol; 2015 Oct; 87(10):1749-53. PubMed ID: 25976377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. I. Prolonged suppression of in vitro lymphocyte responses against CMV infected fibroblasts related to previous secondary CMV infection.
    Roenhorst HW; Middeldorp JM; Beelen JM; Schirm J; Tegzess AM; The TH
    Clin Exp Immunol; 1985 Mar; 59(3):709-15. PubMed ID: 2985307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro stimulation of human colostral lymphocytes by cytomegalovirus.
    Meggs PD; Beer AE
    Am J Obstet Gynecol; 1979 Mar; 133(6):703-7. PubMed ID: 218457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group.
    Haahr S; Møller-Larsen A; Pedersen E
    Clin Exp Immunol; 1983 Feb; 51(2):197-206. PubMed ID: 6188564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of native and recombinant cytomegalovirus antigens in a new ELISA for detection of CMV-specific antibodies.
    Busse C; Strubel A; Schnitzler P
    J Clin Virol; 2008 Oct; 43(2):137-41. PubMed ID: 18621576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immunity to murine cytomegalovirus.
    Howard RJ; Mattsson DM; Seidel MV; Balfour HH
    J Infect Dis; 1978 Nov; 138(5):567-604. PubMed ID: 213500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.